What are the most attractive biotech stocks right now for investors? Seeking Alpha analysts offer their picks. Read more here.

From broad domestic exposure to global pharma and biotech, these funds cover the healthcare sector's main themes.

Sniffing an improvement in capital raising conditions despite geopolitical and other headwinds, a gaggle of biotechs is ...

A Comprehensive Guide to Publicly Traded Companies (2026) The global cannabis and industrial hemp sectors are undergoing a profound structural transformation in 2026. Transitioning from an era ...

This year’s Special 301 report took a meaningful step toward calling out misbehavior of adversaries and allies wherever it ...

Top 10 mid-cap stocks by YTD performance amid market volatility—see 600%+ gainers across semis, biotech & more, plus mid-cap ...

Biotech dealmaking accelerated heading into the JPM 2026 Healthcare Conference as large drugmakers face looming patent cliffs ...

METiS TechBio debuts on Hong Kong stock market as its CEO compares the drug design start-up to SpaceX for the pharmaceutical ...

The chief executive officers of technology and biotech companies in Massachusetts are making millions of dollars.

Regeneron earned approval for a gene therapy for hearing loss. The company's decision to offer it for free makes more sense than it seems at first. The biotech leader has a lot going its way right now ...